Early Access — free while we kick the tires
EdgarHawk

Sabag Mark

See "Remarks"

Officer

Latest: See "Remarks" selling · May 2026

5 filings analyzed · 1 company · Latest 2026-05-04

Companies

Company Buys Sells Direction
TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0 7 Net selling

Activity

May 2026
Sell
144,180 shares
$5,045,118
Significance 4/10

Officer Sabag Mark sells 144,180 TEVA shares (64% of holdings) for $5M; sixth open-market sale in 36 months with mixed timing history.

Mark Sabag, a TEVA officer, executed his sixth open-market sale in the past three years, disposing of roughly two-thirds of his remaining stake for over $5 million. His prior five sales at TEVA showed mixed results: two were well-timed exits where the stock subsequently declined, while three were followed by meaningful gains, suggesting he has historically exited at suboptimal moments more often than not. TEVA itself remains a profitable company with growing revenue and solid quarterly results, but the stock has rallied sharply in recent weeks and now trades near its 52-week high—a position where executives historically take profits more readily. Sabag's sustained pattern of selling, combined with the price level at which this sale occurred, reflects opportunistic liquidation rather than distress or major operational concern, but the repeated exits over three years underscore a pattern of persistent reduction in his personal exposure to the company.

March 2026
Sell
62,102 shares
$1,871,816
Significance 4/10

Sabag Mark sells 62.1K TEVA shares at $30.14; stock down 18.8% from 52-week high, cross-ticker sells average +5.7% 30d return.

Sabag Mark sold 62,102 shares of TEVA at $30.14 on 2026-03-17, reducing his holdings by 21.6% from 287,042 to 224,940 shares. The stock currently trades at $29.44, having declined 18.8% from its 52-week high of $36.25 and fallen 14.4% in the past 30 days. Across his cross-ticker track record, his prior sells averaged a 30-day return of +5.7% and 90-day return of +8.2%, suggesting historical underperformance of this transaction's timing; however, his prior trades at TEVA specifically show mixed timing outcomes, with two December 2025 sales generating 13%+ 30-day returns but only 1 of 5 prior TEVA sales well-timed at the 90-day horizon. TEVA's valuation metrics show a P/E of 9.00 and latest-quarter revenue of $4,480,000,000.00 with net income of $433,000,000.00, supporting a stable financial foundation despite recent share price volatility.

December 2025
Sell
216,892 shares
$6,230,754
Significance 6/10

Sabag Mark sold 216,892 shares for $6.2M at $28.73 avg, reducing holdings by 80.4%; stock at $30.18 after +20.1% 30-day surge

Sabag Mark executed 2 separate sales totaling 216,892 shares for $6,230,754.39 on 2025-12-09, divesting 80.4% of his pre-transaction holdings of 269.7K shares. The sale occurred at a blended average price of $28.73, while the current price stands at $30.18—only 1.4% above the sale price—despite a sharp 30-day rally of +20.1% and a 90-day surge of +51.4%. His prior 3 TEVA sales show mixed timing outcomes: the 2025-05-08 sale was well-timed (90d return -11.3%), the 2025-02-12 sale was poorly timed (90d return +7.6%), and the 2024-03-05 sale was poorly timed (90d return +25.6%), yielding only 1 of 3 well-timed at the 90-day mark. The company's financial profile shows recent deterioration: full-year net income was negative despite positive quarterly earnings of $433.0M, and a stretched P/E of 48.68 reflects elevated valuation. This large concentrated exit, paired with TEVA's recent fundamental weakness and the insider's uneven historical timing at this ticker, warrants close observation of whether this signals meaningful conviction in risk reduction or is simply a discretionary liquidity event.

May 2025
Sell
337,915 shares
$6,097,304
Significance 5/10

Sabag Mark sold 337,915 shares of TEVA at $18.04 on 2025-05-08, reducing holdings by 69.1% to 151.0K shares ($6.1M transaction).

Mark Sabag divested a substantial 337,915 shares at $18.04, representing a 69.1% reduction in his holdings at TEVA. The sale occurred near the 52-week range, with the stock now trading at $17.96, down 21.1% from its $22.77 high. Across Sabag's open-market history at TEVA—two prior trades—his sell timing has not demonstrated consistent foresight: his 2024-03-05 sale yielded a positive 25.6% 90-day return (stock rose after), and his 2025-02-12 sale showed a flat 0.5% 30-day outcome. The company generated $3.9B in quarterly revenue and $214.0M net income, but was unprofitable on a full-year basis, which provides context for monitoring insider trading sentiment. A sale of this magnitude warrants tracking against near-term price and fundamentals to assess whether it reflects changed confidence or was part of a scheduled disposition plan.

February 2025
Sell
177,626 shares
$2,886,565
Significance 5/10

Sabag Mark sold 177,626 shares of TEVA at $16.25 on 2025-02-12, reducing holdings 46.4%; stock now -28.6% from 52-week high

Sabag Mark executed a substantial sell of 177,626 shares (177.6K shares) at $16.25, cutting his holdings nearly in half from 382,590 shares (382.6K shares) to 204,964 shares (205.0K shares). The timing coincides with sharp downward price momentum: TEVA has declined -28.6% from its 52-week high of $22.77 and -25.9% over the past 30 days, trading well below the insider's exit price and deeper into unprofitable territory (most recent quarter showed net income of $-437,000,000.00 with underlying full-year results negative). His prior sell at this ticker on 2024-03-05 generated positive 90-day returns of 25.6%, indicating that particular sale was not well-timed against subsequent stock strength, though the broader cross-ticker track record shows a 0.00% well-timed rate on sells, suggesting no consistent pattern of prescient exit timing.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access